DYRK3 and ovarian serous adenocarcinoma: The above findings underscore the potential of DYRK3 as a robust prognostic marker for overall survival in serous ovarian cancer; thus, we further outlines the results of multivariate Cox regression analysis, offering a nuanced perspective on the factors influencing survival SOC patients (Table 3).